Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-methionine for noise-induced hearing loss
NCT02903355Phase 3
Key facts
- Status
- Terminated
- Start
- Sep 2013
- Primary completion
- Dec 2017
- Countries
- 1
- Sponsor
- Southern Illinois University
- Modality
- Orthosteric Ligands
- Drugs
- methionine
- Conditions
- noise-induced hearing loss (NIHL)tinnitus
01
Overview
Phase 3, randomised, double-blind trial of methionine in noise-induced hearing loss (NIHL) and tinnitus, sponsored by Southern Illinois University. Primary endpoints: ASHA Shift Ear (Left) and ASHA Shift Ear (Right). Started Sep 2013; status: terminated.
02
Design
- Study design
- RandomizedDouble-blind
03
Who it enrols
Healthy Drill Sergeant trainees aged 21-45 with normal hearing thresholds, excluding vegetarians and those using protein supplements.
04
Endpoints
Primary
ASHA Shift Ear (Left)
ASHA Shift Ear (Right)
Beyond the preview
Go deeper on NCT02903355.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02903355.